Hardy Reed LLC United Therapeutics Corp Transaction History
Hardy Reed LLC
- $1.12 Billion
- Q4 2024
A detailed history of Hardy Reed LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Hardy Reed LLC holds 1,219 shares of UTHR stock, worth $454,479. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,219
Previous 1,214
0.41%
Holding current value
$454,479
Previous $435,000
1.15%
% of portfolio
0.04%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding UTHR
# of Institutions
722Shares Held
60.9MCall Options Held
123KPut Options Held
104K-
Wealthfront Advisers LLC18.3MShares$6.83 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$2.04 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.66 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$1.03 Billion14.19% of portfolio
-
Wellington Management Group LLP Boston, MA2.46MShares$919 Million0.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $17B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...